Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - G20

In 2024, the projected revenue in the Treatment of Cardiovascular Diseases market is set to reach a staggering US$0.39tn.
Looking ahead, the market is expected to display a steady annual growth rate (CAGR 2024-2029) of 4.24%.
This growth trajectory will ultimately lead to a market volume of US$0.48tn by 2029.
When comparing this data on a global scale, it becomes evident that in the United States will generate the highest revenue in this market segment.
Specifically, in 2024, in the United States is expected to generate an impressive revenue of US$136.00bn.
This substantiates the significant role in the United States plays in the Treatment of Cardiovascular Diseases market, both within the G20 and on a global level.
In the United States, there is a growing trend towards personalized medicine in the treatment of cardiovascular diseases.

Key regions: China, India, United States, France, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.